Source: Gallery – Christina Lake Cannabis
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Christina Lake Cannabis (CLC) recap its second quarter financial results for the six-month period ended May 31, 2022
  • Total revenue for the six months was $3.9M, exceeding the full fiscal 2021 year-end total of $3.6M
  • Christina Lake is a licensed cannabis producer which cultivates cannabis using strains specifically developed for outdoor cultivation
  • Christina Lake Cannabis Corp. (CLC) remained unchanged, trading at C$0.15 per share at 2:21 pm ET

Christina Lake Cannabis (CLC) recap its second quarter financial results for the six-month period ended May 31, 2022.

Q2 financial highlights:

  • $2.3 million of total revenue, 40 per cent growth over Q1 of 2022 and 971 per cent over Q2 2021
  • Total revenue for the six months was $3.9M, exceeding the full fiscal 2021 year-end total of $3.6M
  • Gross margin before fair value adjustments was 56 per cent versus 55 per cent in Q1 2022 and 67 per cent in Q2 2021

Total general & administrative expenses declined by 70 per cent. This was driven by year-over-year reductions in corporate development, marketing, and share-based compensation expenses.

Net income in Q2 2022 was $22 thousand. The Year-over-year improvement is primarily driven by significant revenue growth and reduced G&A Expenses.

The company posted $184 thousand in positive EBITDA in Q2 2022, compared to a loss of $507 thousand in Q1 2022 and a loss of $1.6 million in Q2 FY2021.

As of May 31, 2022, the company had $1.26 million of cash and $1.03 million in receivables. It entered into a secured promissory note agreement of $2,000,000 with an interest rate of 8 per cent, maturing on August 31, 2024. This was in connection with the redemption and subsequent cancellation of the Class B Preferred Shares.

Christina Lake issued 13,000,000 common shares at $0.20 in connection with the redemption. It also extended the maturities of its $3.1 million of existing convertible debentures from twenty-four months to forty-two months. This reduced the current liabilities by approximately $6.2 million, shifting a large portion of the liabilities out to long-term debt.

The company optimized processing techniques leading to consistent production of high potency distilled oils and other extracts, while adding additional processing capacity. The improvement was a key contributor to the significant increase in the revenue from the prior fiscal year.

Christina Lake is a licensed cannabis producer which cultivates cannabis using strains specifically developed for outdoor cultivation.

Christina Lake Cannabis Corp. (CLC) remained unchanged, trading at C$0.15 per share at 2:21 pm ET.


More From The Market Herald
Isracann Biosciences Inc. - CEO, Phil Floucault

" Isracann Bioscience (CSE:IPOT) facilitated genetics arrive in Israel

Isracann Bioscience (IPOT) announces that its first shipment of cannabis strains has cleared Israeli customs and are being raised as mother stock.
Entourage Health - CEO and Executive Chairman, George Scorsis.

" Entourage (TSXV:ENTG) launches medical cannabis marketplace for the uninsured

Entourage (ENTG) has launched Syndicate, a direct-to-patient medical cannabis marketplace.

" Simply Better Brands (TSXV:SBBC) PureKana Brand, grows 362 per cent vs. one year ago

Simply Better Brands (SBBC) expands its brick-and-mortar retail footprint, which reflects wholesalers, drug stores, convenience stores, as well as CBD specialty retail.
CENTR Brands - CEO, Arjan Chima

" CENTR Brands Corp. (CSE:CNTR) announces net sales growth of over 240 per cent in FY2022

CENTR Brands Corp. (CNTR) announced its audited financial results for the year ending May 31, 2022.